Ashland reports financial results1 for first quarter of fiscal year 2023 consistent with previous updateGlobeNewsWire • 01/31/23
Ashland provides update on fiscal 2023 first-quarter earnings and maintains its financial outlook for fiscal year 2023; sets date for fiscal 2023 first-quarter earnings releaseGlobeNewsWire • 01/25/23
METAFORA partner Wugen to Present Data Supporting Clinical Development of WU-NK-101 for Relapsed / Refractory AML at the American Society of Hematology's (ASH) 64th Annual MeetingBusiness Wire • 12/12/22
Ashland (ASH) Up 4.1% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 12/07/22
Ashland reports financial results(1) for fourth-fiscal quarter; issues outlook for fiscal year 2023GlobeNewsWire • 11/07/22
Ashland injectable pharmaceutical excipient accepted into FDA Novel Excipient Review Pilot ProgramGlobeNewsWire • 10/31/22
Ashland sets date for fiscal 2022 fourth-quarter earnings release and conference call webcastGlobeNewsWire • 10/25/22
Ashland announces expansion of Viatel™ bioresorbable polymers manufacturing and R&D capabilities in Mullingar, IrelandGlobeNewsWire • 08/30/22